Corey M. Priest alias The Root-Cause Rack

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Cancer Support.

Cancer Support

Supports

The influencer claim is extremely vague (“Cancer Support”) but can reasonably be interpreted as suggesting lifestyle or supportive measures (e.g., exercise, diet, nutrition, supportive care) that help people with cancer alongside standard oncologic treatment. High-quality evidence strongly supports the role of structured exercise as a supportive intervention in people with cancer, improving multiple health outcomes, including quality of life, fatigue, physical function, psychological well-being, and treatment-related adverse events. The umbrella review of randomized trials on exercise in cancer patients found 485 associations, with 260 statistically significant and 81 supported by high-certainty evidence; exercise reduced adverse events such as cardiac toxicity, chemotherapy-induced peripheral neuropathy, cognitive impairment, and dyspnea, and improved sleep, psychological well-being, social interaction, and overall quality of life. Earlier systematic reviews and meta-analyses also concluded that aerobic and resistance exercise in cancer survivors yields moderate benefits for cardiovascular fitness and strength and small but consistent benefits for fatigue, health-related quality of life, and depression, with low rates of adverse events. Recent systematic reviews and meta-analyses focused specifically on breast cancer patients show that physical activity improves health-related quality of life, with pooled effect sizes in the moderate range. Mind–body forms of exercise such as yoga, tai chi, and qigong also have supportive evidence for improving depression, anxiety, fatigue, sleep, and health-related quality of life in breast cancer patients, although the strength of evidence varies depending on the specific modality. Nutrition support is also part of mainstream supportive cancer care: ASPEN–FELANPE clinical guidelines emphasize that patients with cancer are at high risk of malnutrition and that individualized nutrition support (oral supplements, enteral or parenteral nutrition when indicated) can improve clinical outcomes, including treatment tolerance and overall status. Dietary patterns such as the Mediterranean diet may provide supportive benefits in breast cancer risk and survivorship: an umbrella review indicates that higher adherence to a Mediterranean diet pattern is associated with reduced risk of breast cancer, particularly in postmenopausal women. Systematic reviews and meta-analyses in breast cancer survivors suggest that Mediterranean-style diets and structured dietary interventions improve diet quality, modestly reduce weight and body fat, and may reduce all-cause mortality, with low certainty but consistent direction of effect. Large meta-analyses of post-diagnosis physical activity show associations between higher activity levels and reduced cancer-specific and all-cause mortality across several major cancer types, supporting exercise as a survival-supportive behavior in addition to symptom management. Taken together, high-quality evidence supports the idea that exercise, appropriate nutrition support, and healthy dietary patterns can meaningfully “support” people with cancer by improving quality of life, functional outcomes, treatment tolerance, and possibly survival when used alongside standard medical care.

Contradicts

Because the influencer’s claim is extremely broad, several potential interpretations would not be supported by high-quality evidence. There is no strong evidence that lifestyle or supportive measures alone can cure cancer or replace surgery, chemotherapy, radiotherapy, immunotherapy, or other standard oncologic treatments; major guidelines and trials consistently treat exercise, diet, and nutrition as adjuncts rather than alternatives. Even where benefits are well supported, effect sizes are usually small to moderate and not universal; exercise improves many outcomes but does not reliably eliminate symptoms or guarantee improved survival for every patient, and evidence quality is often low to moderate. In metastatic or advanced disease, evidence is more limited and sometimes inconclusive: for example, systematic reviews of prescribed exercise in metastatic breast cancer report no clear between-group improvements in quality of life, with substantial uncertainty around effects on fatigue and physical activity. Nutrition guidelines such as ASPEN–FELANPE caution that over- or misapplied nutritional support (e.g., unmonitored parenteral nutrition, extreme diets) can carry risks (infection, metabolic complications) and must be used judiciously. Mediterranean diet evidence for breast cancer risk and survivorship is largely observational and graded as low certainty; while associations are favorable, causality is not established, and benefits may be smaller or absent in some subgroups. Claims that any single lifestyle change (such as a specific diet or exercise regimen) provides universal “cancer support” across all types and stages are therefore overstated relative to the heterogeneous, sometimes weak evidence base.

Mainstream view

The mainstream medical and scientific position is that “cancer support” is best understood as comprehensive

Papers listed for this claim:[1][2][3][4][5][6][7][8][9][10][11][12]

In their own wordsView sourceArchived copy

“Cancer Support”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Cancer

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Autoimmune Conditions.

Autoimmune Conditions

Supports

There is some very preliminary evidence that chiropractic spinal manipulation can transiently change immune-related biomarkers such as cytokines (e.g., IL-6, TNF-α) in adults with spinal pain, suggesting a possible modulation of inflammatory pathways, but these studies do not involve patients with specific autoimmune diseases and do not demonstrate clinical benefit on autoimmune disease activity or outcomes. A pilot randomized trial is underway to examine effects of thoracic spinal manipulation on cytokine levels in patients with relapsing–remitting multiple sclerosis, but this is an exploratory biomarker study and not evidence of disease control or remission in autoimmune disease. Overall, existing randomized trials and mechanistic studies suggest at most short-term changes in immune or stress biomarkers, not disease-modifying effects in autoimmune conditions.

Contradicts

A recent systematic review of spinal manipulative therapy and immune or infectious disease outcomes found no clinical studies demonstrating that spinal manipulation prevents infectious disease or improves disease-specific outcomes; the authors concluded there is no clinical evidence to support or refute claims that spinal manipulation meaningfully changes immune system outcomes, and that the clinical relevance of short-term biomarker changes is unknown. A united position statement from chiropractic researchers similarly concluded that no valid clinical evidence shows chiropractic care can enhance immune function or prevent infections, and emphasized that claims of immune enhancement are unsubstantiated. Major, contemporary autoimmune disease guidelines in rheumatology, gastroenterology, neurology, and related specialties focus on immunosuppressive or immunomodulatory drugs (e.g., corticosteroids, disease-modifying antirheumatic drugs, biologics, targeted synthetic agents), adjunctive nutritional care, and appropriate vaccination, and do not recommend chiropractic or spinal manipulation as a disease-modifying treatment for autoimmune conditions. Guidelines for systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, and other autoimmune diseases specify pharmacologic, nutritional, and rehabilitative strategies but do not list chiropractic care as a therapy for controlling autoimmune disease activity, preventing flares, or modifying long-term outcomes. Existing evidence for chiropractic care in comorbid neurological conditions (e.g., Alzheimer’s or Parkinson’s disease) is limited to small pilot trials assessing EEG changes and does not involve autoimmune pathophysiology or clinical autoimmune endpoints. Overall, claims that chiropractic treatment can treat or control autoimmune diseases themselves are not supported by randomized clinical trials, systematic reviews, or major guidelines.

Mainstream view

The mainstream medical and scientific view is that autoimmune diseases are driven by dysregulated immune responses requiring disease-specific, evidence-based immunomodulatory therapies (such as corticosteroids, conventional and biologic disease-modifying antirheumatic drugs, targeted synthetic agents, and sometimes stem cell or other advanced therapies), along with supportive measures including clinical nutrition, rehabilitation, and vaccination. Clinical practice guidelines across rheumatology, gastroenterology, neurology, and related fields consistently recommend pharmacologic immunosuppression or immunomodulation as the mainstay of treatment and do not recommend chiropractic or spinal manipulation as a primary or disease-modifying therapy for autoimmune conditions. Nonpharmacologic interventions (exercise, physical therapy, psychosocial support) may be recommended for symptom relief and function, but chiropractic care is regarded, at most, as an optional musculoskeletal or pain-management modality without evidence that it alters autoimmune disease activity, prevents progression, or replaces standard immunosuppressive treatment. Mainstream experts and guideline panels therefore consider chiropractic adjustments inappropriate as a stand-alone treatment for autoimmune diseases and emphasize maintaining or initiating guideline-directed immunomodulatory therapy and other standard care measures.

Papers listed for this claim:[4][8][13][14][15][16][17][18][19][20][21][22]

In their own wordsView sourceArchived copy

“Autoimmune Conditions”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Autoimmune disease

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure CIRS (Chronic Inflammatory Response Syndrome).

CIRS (Chronic Inflammatory Response Syndrome)

Supports

High-quality evidence for chiropractic treatment specifically for Chronic Inflammatory Response Syndrome (CIRS) is essentially absent. The main peer‑reviewed review on CIRS treatment concludes that the only intervention with documented clinical efficacy is the Shoemaker Protocol, based on 11 clinical studies, and does not list chiropractic or spinal manipulation among effective treatments. Some randomized and mechanistic studies in other populations (e.g., adults with subclinical spinal pain or chronic low back pain) show that chiropractic spinal manipulation can modulate inflammatory and stress‑related biomarkers (changes in cytokines such as TNF‑α, IL‑6, and immune cell counts), suggesting potential systemic effects on inflammation and neuroendocrine pathways. These findings, however, are exploratory and focused on musculoskeletal pain rather than CIRS as a defined biotoxin‑related syndrome. No major guideline in the list addresses chiropractic care as a recognized treatment for systemic inflammatory syndromes or CIRS; the guidelines listed relate to hypertension, clinical nutrition, parenteral nutrition, tension‑type headache, blood transfusion, and evidence grading, none of which endorse chiropractic as disease‑modifying therapy for systemic inflammatory conditions.

Contradicts

The most relevant peer‑reviewed synthesis on CIRS treatment reports that among identified therapies, only the Shoemaker Protocol has documented clinical efficacy, implying an absence of evidence for other modalities such as chiropractic care as primary or disease‑modifying treatments. CIRS is described as an innate immune dysregulation syndrome, often following exposure to water‑damaged buildings or specific toxins, with treatment approaches targeting specific inflammatory pathways and neuropeptide deficiencies (e.g., vasoactive intestinal peptide replacement) rather than mechanical or musculoskeletal manipulation. This literature positions CIRS as a complex, systemic inflammatory and immunologic illness requiring targeted biomedical interventions, which conflicts with claims that spinal manipulation alone can treat or correct the underlying condition. No randomized controlled trials, systematic reviews, or major guidelines were identified that test or recommend chiropractic care as an effective therapy for CIRS specifically, which represents a major evidentiary gap for such a claim. General clinical effectiveness reviews of chiropractic spinal manipulation highlight benefits mainly for low back pain and some musculoskeletal conditions, and note that even there, high‑quality evidence often finds spinal manipulation not clearly superior to other conservative interventions, arguing against extrapolating to systemic inflammatory syndromes.

Mainstream view

Mainstream medical and scientific views currently regard CIRS as an under‑recognized but biologically plausible chronic inflammatory and innate immune dysregulation syndrome linked to specific environmental or toxin exposures, managed with protocols such as the Shoemaker Protocol and other targeted pharmacologic and environmental interventions. Standard care focuses on accurate diagnosis, removal of ongoing exposure, and stepwise, biomarker‑guided medical treatment (e.g., bile acid sequestrants, anti‑inflammatory and immunomodulatory approaches, and in selected cases VIP replacement), not on chiropractic or spinal manipulation as a core therapeutic modality. Chiropractic care is generally viewed in mainstream medicine as a complementary or alternative therapy primarily for musculoskeletal pain (e.g., low back pain), with some emerging but still limited evidence of short‑term modulation of inflammatory markers; it is not recognized in major guidelines or evidence syntheses as a validated treatment for CIRS or for systemic inflammatory/immune dysregulation syndromes.

Papers listed for this claim:[4][13][8][14][15][16][17][18][23][24][25][26]

In their own wordsView sourceArchived copy

“CIRS (Chronic Inflammatory Response Syndrome)”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Mold illness and CIRS

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Leaky Gut & Digestive Disorders.

Leaky Gut & Digestive Disorders

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Leaky Gut & Digestive Disorders”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on IBS, SIBO and gut disorders

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Lyme Disease.

Lyme Disease

Supports

There is no high-quality evidence from randomized trials, systematic reviews, or major guidelines showing that chiropractic treatment can eradicate Borrelia infection, modify the course of acute Lyme disease, or serve as a primary disease-directed therapy. Major Lyme disease guidelines (e.g., IDSA/AAN/ACR, CDC, NICE, recent guideline summaries) uniformly recommend antibiotics such as doxycycline, amoxicillin, cefuroxime, or ceftriaxone as the evidence-based treatment for Lyme disease, with treatment durations tailored to the clinical manifestation; they do not list chiropractic care as a disease-specific therapy. From an evidence-rating perspective (e.g., GRADE methodology), effective Lyme disease treatments are those with proven antimicrobial activity and demonstrated benefit in controlled studies, which chiropractic techniques lack. Chiropractic or other musculoskeletal therapies may have a role in symptomatic management of nonspecific pain or tension-type headaches in general, but this is indirect and not specific to Lyme disease, and existing headache guidelines emphasize pharmacologic and behavioral approaches rather than chiropractic as core treatment.

Contradicts

Major clinical guidelines and reviews on Lyme disease consistently state that appropriate antibiotic therapy is required to treat the infection and prevent or reduce complications, and they do not endorse chiropractic treatment as a substitute or primary therapy. Infectious disease guidelines also explicitly advise against non-evidence-based or prolonged non-antibiotic regimens for presumed chronic Lyme without clear diagnostic support, underscoring that non-antimicrobial modalities cannot be relied upon to clear infection. The general framework for rating evidence quality and clinical recommendations (e.g., GRADE) would classify chiropractic treatment for Lyme disease as very low-quality or unsupported, since there are no controlled trials, no biologically plausible antimicrobial mechanism, and no guideline endorsement. Furthermore, Lyme disease is a systemic bacterial infection; standard medical texts and guidelines emphasize antibiotic treatment and, for neurologic or cardiac involvement, specific intravenous regimens, again with no mention of chiropractic care as disease-modifying therapy.

Mainstream view

The mainstream medical and scientific position is that Lyme disease is a bacterial infection (usually Borrelia burgdorferi) that requires timely diagnosis and evidence-based antibiotic therapy to treat the infection and prevent complications. Recommended treatments include oral doxycycline, amoxicillin, cefuroxime, or azithromycin for early localized or some disseminated forms, and intravenous ceftriaxone or similar agents for certain neurologic or cardiac manifestations, with durations typically between 10 and 28 days depending on the clinical presentation. Chiropractic care is not recognized as a disease-directed treatment for Lyme disease; at most, it may be considered an adjunctive option for general musculoskeletal pain or functional complaints, provided it does not delay or replace appropriate antibiotic therapy. Mainstream guidelines do not list chiropractic treatment among recommended interventions for Lyme disease, and evidence-based practice frameworks would regard claims that chiropractic can treat or cure Lyme disease as unsupported.

Papers listed for this claim:[4][8][13][14][15][16][17][18][27][28][29][30]

In their own wordsView sourceArchived copy

“Lyme Disease”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Lyme disease

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Mold Toxicity.

Mold Toxicity

Supports

There is no high-quality evidence in the listed papers supporting chiropractic treatment for mold toxicity. The closest relevant peer-reviewed item is a review on mold/mycotoxins that discusses potential biological effects of exposure, but it does not evaluate chiropractic as a treatment . Major clinical guidance for mold exposure focuses on exposure reduction, diagnosis of allergic or respiratory disease, and standard medical management rather than chiropractic care.

Contradicts

The claim is contradicted by the absence of randomized trials, systematic reviews, or major guidelines showing that chiropractic treats mold toxicity. The peer-reviewed materials listed are about unrelated conditions such as hypertension, nutrition, headaches, transfusion, and pericarditis, and none support chiropractic treatment for mold-related illness. External medical guidance summarized in the search results states that evidence does not support inhaled mycotoxins from indoor mold as a cause of systemic toxicity and emphasizes evidence-based care instead. That makes a chiropractic treatment claim especially weak when it is presented as treatment for a toxic syndrome.

Mainstream view

The mainstream medical view is that chiropractic is not an evidence-based treatment for mold toxicity. Standard management of suspected mold-related illness centers on identifying and removing exposure, evaluating for asthma, allergy, or other established diagnoses, and treating those conditions with conventional medical care; claims of a chiropractic cure or specific chiropractic detoxification approach are unsupported.

Papers listed for this claim:[4][8][13][14][15][16][17][18][31][32][33][34]

In their own wordsView sourceArchived copy

“Mold Toxicity”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Mold illness and CIRS

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Thyroid Disorders.

Thyroid Disorders

Supports

There are no high-quality randomized controlled trials, systematic reviews, or major endocrine guidelines showing that chiropractic spinal manipulation is an effective primary treatment for thyroid disorders (hypothyroidism, hyperthyroidism, autoimmune thyroid disease, thyroid nodules, or thyroid cancer). The only directly relevant clinical trial identified is a protocol for a pilot RCT of Neuro-Emotional Technique (a biopsychosocial/chiropractic-linked modality) added to usual care in overt hypothyroidism, which is designed to look at mood and thyroid lab changes but does not yet provide results; this shows interest in studying adjunctive non-pharmacologic approaches but does not constitute evidence of efficacy at this stage. Case reports and small case series from chiropractic-oriented journals describe individual patients whose thyroid function or medication requirements appeared to improve during chiropractic care, but these are uncontrolled, low-quality observations and not high-quality evidence.

Contradicts

Major, evidence-based clinical practice guidelines for thyroid disease consistently recommend pharmacologic and/or surgical management as the standard of care and do not endorse chiropractic manipulation as a treatment for thyroid disorders. For primary hypothyroidism, guidelines emphasize diagnosis based on thyroid-stimulating hormone (TSH) and free thyroxine, and treatment with levothyroxine titrated to normalize TSH and relieve symptoms; they specifically discuss dose ranges, monitoring intervals, and target TSH, but do not include chiropractic care in any treatment algorithms. These guidelines are built from systematic reviews and high-quality evidence, and state that alternative preparations (e.g., natural thyroid extract) are not recommended, reinforcing that thyroid hormone replacement—not musculoskeletal manipulation—is the evidence-based therapy. Current thyroid disease guidelines for pregnancy and postpartum similarly focus on appropriate thyroid hormone replacement, antithyroid drugs, and surgery or radioiodine where indicated, again without any role for chiropractic as treatment. More broadly, guideline methodologies such as GRADE emphasize that low-quality, imprecise evidence (e.g., case reports and uncontrolled series) cannot support strong treatment recommendations, which applies directly to the chiropractic thyroid case literature.

Mainstream view

The mainstream medical and scientific position is that chiropractic care is not an evidence-based treatment for thyroid disorders and should not be relied on to manage hypothyroidism, hyperthyroidism, autoimmune thyroid disease, thyroid nodules, or thyroid cancer. Thyroid diseases are diagnosed and managed primarily by physicians (often endocrinologists) using standardized biochemical testing (TSH, free T4, free T3, antibodies) and imaging, with treatment centered on thyroid hormone replacement (e.g., levothyroxine), antithyroid medications, radioiodine, or surgery depending on the specific condition, guided by national and international clinical practice guidelines. These guidelines are based on systematic reviews and high-quality trials and do not recommend chiropractic manipulation either as primary therapy or as a routine adjunct for modifying thyroid physiology or disease course. Within mainstream practice, chiropractic may be considered for musculoskeletal complaints (e.g., neck or back pain) but not as a therapeutic modality for endocrine disorders like thyroid disease; any use of chiropractic in patients with thyroid disease is viewed, at most, as supportive for general musculoskeletal well-being, not as a treatment that can correct thyroid hormone abnormalities or replace guideline-directed medical care.

Papers listed for this claim:[4][8][13][14][15][16][17][18][35][36][37][38]

In their own wordsView sourceArchived copy

“Thyroid Disorders”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Thyroid disease and Hashimoto

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Chronic Fatigue.

Chronic Fatigue

Supports

High-quality evidence specific to chiropractic treatment for chronic fatigue syndrome (CFS) or chronic fatigue is very limited. The available literature includes a prospective, uncontrolled clinical series of upper cervical chiropractic care in 19 patients with CFS that reported improvements in SF-36 general and mental health scores and sleep quality over 6 months, but this study lacked a control group and was conducted by a single practitioner, making it low-quality evidence rather than robust support. More broadly, systematic reviews of complementary and alternative medicine (CAM) for CFS report that some manual therapies (such as massage and tuina) show positive effects on fatigue, mood, and sleep in randomized controlled trials, but they emphasize that methodological weaknesses and high risk of bias prevent firm conclusions about efficacy for CFS as a whole. Recent meta-analyses of massage therapy in CFS, pooling multiple randomized trials, suggest statistically significant reductions in fatigue and improved effective rates compared with control conditions, indicating that some forms of manual therapy can have symptomatic benefit, though these data are not specific to spinal manipulation or chiropractic techniques. Overall, the only support for chiropractic treatment of chronic fatigue is indirect, through the broader manual-therapy/CAM literature and one small uncontrolled chiropractic series, and does not constitute high-quality evidence that chiropractic care is an effective, disease-modifying treatment for chronic fatigue syndrome.

Contradicts

Systematic reviews of CAM interventions for CFS consistently conclude that evidence is insufficient to determine efficacy, primarily due to small sample sizes, poor blinding, inadequate controls, and high risk of bias; they explicitly state that even where qigong, massage, or tuina show apparent benefits, the study quality precludes firm claims of effectiveness for CFS. More recent methodological reviews of randomized trials in CFS emphasize that no single intervention, including physical or manual therapies, has demonstrated consistently reproducible, robust effects across high-quality trials, underscoring the experimental and uncertain nature of these approaches. Mainstream guideline and review documents focus on cognitive-behavioral interventions, graded activity programs, symptom-targeted pharmacologic treatment, and pacing/energy management; they do not recommend chiropractic spinal manipulation as a core or evidence-based therapy for CFS. The lack of randomized, controlled, adequately powered trials of chiropractic care in CFS, combined with reliance on case reports and uncontrolled series, directly contradicts any strong claim that chiropractic treatment is a proven or established therapy for chronic fatigue. Furthermore, because CFS/ME is a complex, multisystem neuroimmune condition, current reviews do not support theoretical models that spinal manipulation alone can correct the underlying pathophysiology or reliably resolve chronic fatigue symptoms.

Mainstream view

The mainstream medical position is that myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a chronic, multisystem illness with unclear etiology and no single curative treatment. Evidence-based management focuses on accurate diagnosis, ruling out alternative causes of fatigue, and then using individualized, multimodal strategies such as activity pacing, cognitive-behavioral approaches for coping, treatment of comorbid sleep, pain, mood, or orthostatic intolerance disorders, and careful symptom-directed pharmacologic therapy. Non-pharmacologic adjuncts including certain forms of manual therapy, massage, or other CAM modalities may be considered for some patients on a case-by-case basis, but major guidelines and systematic reviews characterize these as optional, supportive, and of uncertain efficacy rather than primary treatments. Chiropractic care, specifically spinal manipulation by chiropractors, is not recognized in major guidelines as an evidence-based core treatment for CFS/ME or chronic fatigue, and the existing research base is regarded as preliminary, low quality, and insufficient to justify strong claims. In mainstream practice, chiropractic interventions might be used to address coexisting musculoskeletal pain or dysfunction, but not as a validated primary therapy for the fatigue syndrome itself.

Papers listed for this claim:[39][40][41][42]

In their own wordsView sourceArchived copy

“Chronic Fatigue”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Chronic fatigue and fibromyalgia

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure We take a comprehensive, integrative approach to cancer care.

We take a comprehensive, integrative approach to cancer care

Supports

High-quality evidence and major guidelines support the idea of integrative oncology as a patient-centered, evidence-informed component of comprehensive cancer care when used alongside, not instead of, conventional oncologic treatment. Multiple Society for Integrative Oncology (SIO)–ASCO joint guidelines state that integrative oncology "utilizes mind and body practices, natural products, and/or lifestyle modifications from different traditions alongside conventional cancer treatments" and explicitly describe it as part of comprehensive cancer care. These guidelines cover symptom management domains such as pain, anxiety, depression, and fatigue, recommending modalities like mindfulness-based interventions, yoga, acupuncture, massage, and exercise for specific indications, based on randomized trials and systematic reviews. Large oncology societies (ASCO, NCCN) have endorsed several SIO practice guidelines and incorporate selected integrative modalities into mainstream supportive care, which supports the notion that an evidence-based integrative program can legitimately be described as part of comprehensive cancer care. The listed clinical trials (miconazole resistance in neonates and infants, nab‑paclitaxel plus gemcitabine in pancreatic cancer, metformin for anti‑aging in prediabetes, swaddle bathing in preterm infants, remote upper GI examination, thyroid surgery vocal cord palsy risk factors, musculoskeletal stretching techniques for text neck, and camlipixant pharmacokinetics) do not directly address integrative oncology or comprehensive integrative cancer programs and therefore do not specifically support or refute the influencer’s claim.

Contradicts

Major guidelines and evidence sources do not support integrative oncology as a stand‑alone primary cancer treatment and consistently warn against using complementary or integrative modalities as replacements for evidence‑based surgery, systemic therapy, or radiotherapy. Joint SIO–ASCO guidelines explicitly frame integrative approaches as adjunctive for symptom management and quality of life, not as curative treatments or substitutes for standard oncologic care. They also emphasize that evidence for many integrative modalities is limited, with only a subset (eg, acupuncture for pain or chemotherapy-induced nausea and vomiting, certain mindfulness-based programs, exercise, and select mind–body practices) having moderate-quality evidence and guideline-level recommendations, while many other supplements and practices either lack sufficient evidence or are specifically discouraged due to absence of benefit or potential harm. Thus, any implication that an "integrative" approach alone constitutes comprehensive cancer treatment, or that unproven modalities can replace conventional therapy, is not supported by high-quality evidence or guidelines. The trials listed are unrelated to integrative oncology and therefore do not provide evidence that a particular influencer’s "comprehensive, integrative" cancer program is effective or complete as a treatment strategy.

Mainstream view

The mainstream medical position is that integrative oncology is an evidence-informed, adjunctive field that can appropriately be part of comprehensive cancer care when it is used to complement, not replace, conventional oncologic treatments. Leading organizations such as ASCO, SIO, and NCCN recognize and endorse selected integrative therapies for symptom control, psychological support, and survivorship issues, and they have issued multiple joint guidelines based on randomized trials, systematic reviews, and meta-analyses. These guidelines define integrative oncology as patient-centered and comprehensive in the sense that it addresses physical, psychological, and lifestyle aspects of care, but they also clearly restrict its role to support and symptom management and emphasize that core cancer treatment must follow evidence-based standards in surgery, systemic therapy, and radiation. Mainstream practice therefore supports a comprehensive, integrative approach only when it remains grounded in guideline-based conventional care, uses integrative modalities with demonstrated benefit for specific indications, avoids unproven or harmful interventions, and is transparently described to patients as supportive care rather than an alternative cure. The listed trials are not directly about integrative oncology and do not change this mainstream view.

Papers listed for this claim:[43][44][45][46]

In their own wordsView sourceArchived copy

“We take a comprehensive, integrative approach to cancer care”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Cancer

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Functional labs can uncover… Insulin resistance ... Hormonal imbalances.

Functional labs can uncover… Insulin resistance ... Hormonal imbalances

Supports

Mainstream endocrinology and internal medicine rely on standard laboratory tests to detect insulin resistance and clinically relevant hormonal disorders. These include fasting plasma glucose, oral glucose tolerance test, and HbA1c, with more specialized methods such as the hyperinsulinemic euglycemic clamp and intravenous glucose tolerance tests used as reference standards in research settings to assess insulin sensitivity and resistance. High‑quality reviews emphasize that dynamic glucose tolerance tests and validated hormone assays are central for diagnosing insulin resistance and endocrine disease, which is consistent with the idea that appropriately selected laboratory investigations can uncover insulin resistance and hormonal abnormalities when used according to evidence‑based protocols. Major endocrine guidelines stress the need for accurate, standardized hormone assays (for example, testosterone) and rigorously derived reference ranges when diagnosing androgen deficiency, reinforcing that lab‑based hormone testing is a core, evidence‑supported tool for identifying true hormonal imbalances rather than relying solely on symptoms.

Contradicts

Evidence‑based laboratory medicine and guideline documents distinguish between appropriate diagnostic laboratory use and the broad, non‑selective test panels often marketed as “functional labs.” Studies of test utilization in functional medicine practices show extensive ordering of expensive hormone and metabolic tests without guideline‑based indications, with the majority of results returning normal, which suggests overuse rather than improved detection of clinically meaningful disease. International guidance on assessing insulin resistance notes that routine clinical measurement of insulin resistance using surrogate indices such as fasting insulin or HOMA‑IR is not recommended for general clinical practice because these metrics are imprecise and better reserved for research, indicating that many insulin‑resistance focused “functional” panels are weakly supported by high‑quality evidence. Overall, high‑quality guidelines emphasize targeted, validated tests linked to specific clinical questions; they do not endorse broad functional lab panels as a superior or necessary approach for uncovering insulin resistance or vague hormonal imbalance in otherwise well individuals, so claims that functional labs uniquely “uncover” these problems go beyond the strength of current evidence.

Mainstream view

The mainstream position is that laboratory tests are essential for diagnosing insulin resistance and endocrine disorders, but they should be ordered selectively, using validated assays and established diagnostic criteria, and interpreted within an evidence‑based framework. For insulin resistance, mainstream practice focuses on identifying prediabetes and diabetes using fasting plasma glucose, oral glucose tolerance testing, and HbA1c, with specialized methods like hyperinsulinemic euglycemic clamps reserved for research or complex cases, rather than routine use of expanded functional panels. For hormonal imbalances, major societies recommend making diagnoses only when characteristic symptoms are present and hormone levels are unequivocally abnormal on accurate assays, using standardized cutoffs and repeat testing, rather than relying on broad hormone panels or nonstandard “optimal ranges.” Consequently, mainstream medicine supports the use of appropriate lab testing to detect insulin resistance and hormone disorders, but does not support the routine use of large, non‑targeted functional lab panels as a superior or necessary diagnostic strategy.

Papers listed for this claim:[4][8][13][15][16][14][17][18][47][48][49][50]

In their own wordsView sourceArchived copy

“Functional labs can uncover… Insulin resistance ... Hormonal imbalances”

Rule: K.S.A. 65-2871

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure CIRS.

CIRS

Supports

High-quality evidence for chiropractic treatment specifically for Chronic Inflammatory Response Syndrome (CIRS) is essentially absent. The main peer‑reviewed review on CIRS treatment concludes that the only intervention with documented clinical efficacy is the Shoemaker Protocol, based on 11 clinical studies, and does not list chiropractic or spinal manipulation among effective treatments. Some randomized and mechanistic studies in other populations (e.g., adults with subclinical spinal pain or chronic low back pain) show that chiropractic spinal manipulation can modulate inflammatory and stress‑related biomarkers (changes in cytokines such as TNF‑α, IL‑6, and immune cell counts), suggesting potential systemic effects on inflammation and neuroendocrine pathways. These findings, however, are exploratory and focused on musculoskeletal pain rather than CIRS as a defined biotoxin‑related syndrome. No major guideline in the list addresses chiropractic care as a recognized treatment for systemic inflammatory syndromes or CIRS; the guidelines listed relate to hypertension, clinical nutrition, parenteral nutrition, tension‑type headache, blood transfusion, and evidence grading, none of which endorse chiropractic as disease‑modifying therapy for systemic inflammatory conditions.

Contradicts

The most relevant peer‑reviewed synthesis on CIRS treatment reports that among identified therapies, only the Shoemaker Protocol has documented clinical efficacy, implying an absence of evidence for other modalities such as chiropractic care as primary or disease‑modifying treatments. CIRS is described as an innate immune dysregulation syndrome, often following exposure to water‑damaged buildings or specific toxins, with treatment approaches targeting specific inflammatory pathways and neuropeptide deficiencies (e.g., vasoactive intestinal peptide replacement) rather than mechanical or musculoskeletal manipulation. This literature positions CIRS as a complex, systemic inflammatory and immunologic illness requiring targeted biomedical interventions, which conflicts with claims that spinal manipulation alone can treat or correct the underlying condition. No randomized controlled trials, systematic reviews, or major guidelines were identified that test or recommend chiropractic care as an effective therapy for CIRS specifically, which represents a major evidentiary gap for such a claim. General clinical effectiveness reviews of chiropractic spinal manipulation highlight benefits mainly for low back pain and some musculoskeletal conditions, and note that even there, high‑quality evidence often finds spinal manipulation not clearly superior to other conservative interventions, arguing against extrapolating to systemic inflammatory syndromes.

Mainstream view

Mainstream medical and scientific views currently regard CIRS as an under‑recognized but biologically plausible chronic inflammatory and innate immune dysregulation syndrome linked to specific environmental or toxin exposures, managed with protocols such as the Shoemaker Protocol and other targeted pharmacologic and environmental interventions. Standard care focuses on accurate diagnosis, removal of ongoing exposure, and stepwise, biomarker‑guided medical treatment (e.g., bile acid sequestrants, anti‑inflammatory and immunomodulatory approaches, and in selected cases VIP replacement), not on chiropractic or spinal manipulation as a core therapeutic modality. Chiropractic care is generally viewed in mainstream medicine as a complementary or alternative therapy primarily for musculoskeletal pain (e.g., low back pain), with some emerging but still limited evidence of short‑term modulation of inflammatory markers; it is not recognized in major guidelines or evidence syntheses as a validated treatment for CIRS or for systemic inflammatory/immune dysregulation syndromes.

Papers listed for this claim:[4][13][8][14][15][16][17][18][23][24][25][26]

In their own wordsView sourceArchived copy

“CIRS”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Mold illness and CIRS

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Innovations in Cancer Care.

Innovations in Cancer Care

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Innovations in Cancer Care”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Cancer

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Intestinal permeability (leaky gut).

Intestinal permeability (leaky gut)

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Intestinal permeability (leaky gut)”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on IBS, SIBO and gut disorders

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Blood sugar regulation and insulin resistance.

Blood sugar regulation and insulin resistance

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Blood sugar regulation and insulin resistance”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Diabetes and blood sugar

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Insulin resistance.

Insulin resistance

Supports

Mainstream endocrinology and internal medicine rely on standard laboratory tests to detect insulin resistance and clinically relevant hormonal disorders. These include fasting plasma glucose, oral glucose tolerance test, and HbA1c, with more specialized methods such as the hyperinsulinemic euglycemic clamp and intravenous glucose tolerance tests used as reference standards in research settings to assess insulin sensitivity and resistance. High‑quality reviews emphasize that dynamic glucose tolerance tests and validated hormone assays are central for diagnosing insulin resistance and endocrine disease, which is consistent with the idea that appropriately selected laboratory investigations can uncover insulin resistance and hormonal abnormalities when used according to evidence‑based protocols. Major endocrine guidelines stress the need for accurate, standardized hormone assays (for example, testosterone) and rigorously derived reference ranges when diagnosing androgen deficiency, reinforcing that lab‑based hormone testing is a core, evidence‑supported tool for identifying true hormonal imbalances rather than relying solely on symptoms.

Contradicts

Evidence‑based laboratory medicine and guideline documents distinguish between appropriate diagnostic laboratory use and the broad, non‑selective test panels often marketed as “functional labs.” Studies of test utilization in functional medicine practices show extensive ordering of expensive hormone and metabolic tests without guideline‑based indications, with the majority of results returning normal, which suggests overuse rather than improved detection of clinically meaningful disease. International guidance on assessing insulin resistance notes that routine clinical measurement of insulin resistance using surrogate indices such as fasting insulin or HOMA‑IR is not recommended for general clinical practice because these metrics are imprecise and better reserved for research, indicating that many insulin‑resistance focused “functional” panels are weakly supported by high‑quality evidence. Overall, high‑quality guidelines emphasize targeted, validated tests linked to specific clinical questions; they do not endorse broad functional lab panels as a superior or necessary approach for uncovering insulin resistance or vague hormonal imbalance in otherwise well individuals, so claims that functional labs uniquely “uncover” these problems go beyond the strength of current evidence.

Mainstream view

The mainstream position is that laboratory tests are essential for diagnosing insulin resistance and endocrine disorders, but they should be ordered selectively, using validated assays and established diagnostic criteria, and interpreted within an evidence‑based framework. For insulin resistance, mainstream practice focuses on identifying prediabetes and diabetes using fasting plasma glucose, oral glucose tolerance testing, and HbA1c, with specialized methods like hyperinsulinemic euglycemic clamps reserved for research or complex cases, rather than routine use of expanded functional panels. For hormonal imbalances, major societies recommend making diagnoses only when characteristic symptoms are present and hormone levels are unequivocally abnormal on accurate assays, using standardized cutoffs and repeat testing, rather than relying on broad hormone panels or nonstandard “optimal ranges.” Consequently, mainstream medicine supports the use of appropriate lab testing to detect insulin resistance and hormone disorders, but does not support the routine use of large, non‑targeted functional lab panels as a superior or necessary diagnostic strategy.

Papers listed for this claim:[4][8][13][15][16][14][17][18][47][48][49][50]

In their own wordsView sourceArchived copy

“Insulin resistance”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Diabetes and blood sugar

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Hormonal imbalances (thyroid, cortisol, sex hormones).

Hormonal imbalances (thyroid, cortisol, sex hormones)

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Hormonal imbalances (thyroid, cortisol, sex hormones)”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Hormone imbalance and replacement

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure The Thyroid Example.

The Thyroid Example

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“The Thyroid Example”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Thyroid disease and Hashimoto

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Thyroid peroxidase antibodies (TPOAb).

Thyroid peroxidase antibodies (TPOAb)

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Thyroid peroxidase antibodies (TPOAb)”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Thyroid disease and Hashimoto

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Detect autoimmune thyroid conditions.

Detect autoimmune thyroid conditions

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Detect autoimmune thyroid conditions”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Thyroid disease and Hashimoto

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Let’s look at autoimmune disease as an example as within their scope of practice.

Let’s look at autoimmune disease as an example

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Let’s look at autoimmune disease as an example”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Autoimmune disease

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure High Blood Pressure.

High Blood Pressure

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“High Blood Pressure”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Heart disease and cholesterol

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Heart Disease.

Heart Disease

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Heart Disease”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Heart disease and cholesterol

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure High Cholesterol.

High Cholesterol

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“High Cholesterol”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Heart disease and cholesterol

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Celiac Disease.

Celiac Disease

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Celiac Disease”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Autoimmune disease

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Diabetes.

Diabetes

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Diabetes”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Diabetes and blood sugar

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Pre-Diabetic.

Pre-Diabetic

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Pre-Diabetic”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Diabetes and blood sugar

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Irritable Bowel Syndrome (IBS).

Irritable Bowel Syndrome (IBS)

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Irritable Bowel Syndrome (IBS)”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on IBS, SIBO and gut disorders

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Cognitive Decline & Brain Fog.

Cognitive Decline & Brain Fog

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Cognitive Decline & Brain Fog”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Dementia and Alzheimer disease

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Complex Chronic Illness.

Complex Chronic Illness

Supports

High-quality evidence supports chiropractic spinal manipulation as one option for symptom management in certain chronic musculoskeletal conditions, especially chronic low back pain, but not as a disease-modifying treatment for complex multisystem chronic illnesses. A large systematic review of randomized controlled trials found that spinal manipulative therapy provides pain and disability improvements similar to other recommended therapies (such as exercise) for chronic low back pain, indicating it can be a reasonable nonpharmacologic option in this specific context. A practice-based randomized controlled trial in chronic low back pain showed that 6–18 sessions of chiropractic spinal manipulation yielded modest but statistically significant improvements in pain and disability over a massage-like control, with effects sustained up to one year, again supporting use for chronic mechanical low back pain but not broader complex chronic illness. Consensus-based chiropractic clinical practice guidelines for chronic musculoskeletal pain recommend spinal manipulation, exercise, and other nonpharmacologic therapies as part of multimodal management, often in coordination with other healthcare professionals, for conditions such as chronic low back pain and sometimes fibromyalgia, but these documents explicitly frame chiropractic as part of supportive, evidence-informed care rather than a standalone cure for complex chronic disease. A UK evidence report on manual therapies concluded that evidence for spinal manipulation is favorable or comparable to other conservative treatments for some musculoskeletal pain conditions, again supporting a role in symptom relief but not systemic control of complex chronic diseases. Recent randomized trials in people with chronic stroke and chronic primary pain report biologic or neuroplasticity-related biomarker changes and pain-related improvements after chiropractic spinal adjustments compared with sham, suggesting possible mechanistic and symptomatic benefits; however, these are early studies and relate to specific neurologic or pain phenotypes rather than general complex chronic illness. Guidelines for chronic condition management in other domains (e.g., hypertension, inflammatory bowel disease, parenteral nutrition, tension-type headache) emphasize structured medical, nutritional, and pharmacologic care and allow space for nonpharmacologic and self-management strategies which could, in principle, include manual therapies as adjuncts, but they do not specifically endorse chiropractic as core treatment. Overall, the best-supported role for chiropractic is as an adjunctive, nonpharmacologic therapy for chronic musculoskeletal pain (especially low back pain) within multidisciplinary management of chronic disease, not as primary treatment for complex chronic illnesses.

Contradicts

For complex chronic illnesses such as fibromyalgia, chronic fatigue syndrome, and other multisystem disorders, systematic reviews and major evidence syntheses consistently find insufficient or inconclusive evidence that chiropractic care is effective. A systematic review of randomized clinical trials on chiropractic treatment for fibromyalgia identified only three poor-quality trials and concluded there is no evidence that chiropractic care is effective for fibromyalgia. Another systematic review of chiropractic management of fibromyalgia noted that multiple nonpharmacologic and manual therapies have some evidentiary support, but did not find robust randomized trial data specifically validating chiropractic interventions for this condition. The UK evidence report on manual therapies explicitly judged the evidence for spinal manipulation in fibromyalgia as inconclusive and stated that current trial evidence is insufficient to conclude that chiropractic is an effective treatment for fibromyalgia. Major clinical guidelines for complex chronic conditions such as hypertension, inflammatory bowel disease, and nutrition in serious chronic disease focus on pharmacologic therapy, dietary management, and structured medical follow-up; they do not recommend chiropractic as disease-targeting treatment for these conditions, indicating a lack of evidence for chiropractic in controlling pathophysiology or disease progression. High-quality methodological guidance for evidence grading emphasizes imprecision, risk of bias, and indirectness; applied to the chiropractic literature in complex chronic illness (e.g., fibromyalgia), these criteria highlight that available trials are underpowered, at risk of bias, and not sufficient to support strong claims of efficacy. There is no high-quality evidence showing that chiropractic care can replace guideline-directed medical therapy for major chronic diseases (e.g., cardiovascular disease, inflammatory bowel disease, severe metabolic syndromes), and existing chronic care and telemonitoring trials for complex conditions rely on medical, behavioral, and technological interventions rather than chiropractic. Thus, any broad claim that chiropractic treatment effectively manages or cures complex chronic illness in general is not supported by current peer-reviewed evidence and conflicts with guidelines and systematic reviews.

Mainstream view

The mainstream medical and scientific position is that chiropractic spinal

Papers listed for this claim:[4][8][13][14][15][16][17][18][51][52][53][54]

In their own wordsView sourceArchived copy

“Complex Chronic Illness”

Rule: K.S.A. 65-2871

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise Discover the root cause of your health issues as within their scope of practice.

Discover the root cause of your health issues

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Discover the root cause of your health issues”

Rule: K.S.A. 65-2871

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise advanced, targeted lab testing reveals what’s actually happening beneath the surface as within their scope of practice.

advanced, targeted lab testing reveals what’s actually happening beneath the surface

Supports

There is high-quality evidence that some forms of targeted laboratory testing, when clearly linked to a specific disease mechanism or treatment decision, can reveal clinically important information not apparent from routine evaluation. For example, plasma PIK3CA mutation testing in hormone receptor–positive, HER2‑negative advanced breast cancer allows identification of patients who benefit from PI3K inhibitors; robust clinical evidence and professional recommendations support this personalized, targeted testing as adding real value beyond surface-level clinical assessment. Advanced point‑of‑care testing in emergency departments can shorten length of stay when integrated into workflows, supporting the idea that rapid, targeted assays can improve care processes by revealing time‑sensitive information efficiently. Precision and personalized medicine more broadly (e.g., pharmacogenomics, biomarker-guided therapy) relies on targeted laboratory and molecular tests to uncover underlying biology that is not evident from standard clinical examination, and this approach is increasingly supported by narrative and systematic reviews and by major oncology and cardiology guidelines.

Contradicts

The broad, unqualified claim that “advanced, targeted lab testing reveals what’s actually happening beneath the surface” across general health or functional medicine is not supported by high‑quality evidence. Large randomized trials summarized in a Cochrane review show that routine general health checks with broad laboratory panels in adults, on top of guideline‑directed screening, do not reduce all‑cause, cancer, or cardiovascular mortality, indicating that extensive lab screening often fails to improve hard outcomes despite revealing more biochemical abnormalities. Professional societies participating in initiatives such as Choosing Wisely repeatedly warn against overuse of laboratory tests that are not tied to a clear clinical question, emphasizing that many commonly ordered or “advanced” tests add cost and potential harm without meaningful benefit. Guidelines specifically advise against routine use of expanded lipid panels, non‑indicated vitamin assays, repeated tests at short intervals, and generalized executive lab panels in asymptomatic individuals, arguing that they do not reliably provide deeper, actionable insight into underlying health beyond standard evidence‑based tests. Thus, while some targeted tests are useful in defined contexts, the influencer’s implication that advanced testing broadly and reliably reveals the true underlying state of health is much stronger than what the evidence supports.

Mainstream view

The mainstream medical and scientific position is that laboratory testing should be targeted, evidence‑based, and ordered in response to specific clinical questions, not used indiscriminately to search for hidden problems. Major guideline bodies and stewardship initiatives recommend limiting testing to assays with demonstrated clinical utility—tests that change diagnosis, risk stratification, or management in ways that improve outcomes—and they actively discourage routine broad panels or unvalidated “advanced” tests in otherwise healthy or nonspecific cases. Targeted molecular and biomarker tests (such as PIK3CA mutation assays in advanced breast cancer) are endorsed when supported by strong trials and guidelines, but generalized claims that advanced testing will always reveal what is happening “beneath the surface” are considered overstated. The accepted view is that some advanced targeted tests do provide deeper, clinically relevant insight, but only in well‑defined scenarios with proven utility; outside those contexts, extensive testing often yields incidental or non‑actionable findings and may cause harm through overdiagnosis, anxiety, and unnecessary interventions.

Papers listed for this claim:[55][56][57][58]

In their own wordsView sourceArchived copy

“advanced, targeted lab testing reveals what’s actually happening beneath the surface”

Rule: K.S.A. 65-2871

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise develop a personalized protocol to support your goals and needs as within their scope of practice.

develop a personalized protocol to support your goals and needs

Supports

The claim is broadly consistent with guideline-based care in several conditions: hypertension management is explicitly described as evidence-based and individualized in the cited update, which supports tailoring treatment to patient factors, comorbidities, and goals . Nutrition guidelines for inflammatory bowel disease and parenteral nutrition also emphasize individualized assessment and selection of interventions based on clinical need rather than a one-size-fits-all approach . Colchicine guidance for pericarditis supports using patient-specific risk/benefit considerations when selecting therapy .

Contradicts

The claim is very broad and not itself a medical intervention, diagnosis, or outcome claim, so there is little direct high-quality evidence that can verify it as a standalone statement. Major guidelines generally support individualized management within defined evidence-based protocols, not self-created protocols unconstrained by diagnosis or clinician oversight . The GRADE evidence framework highlights that certainty can be limited by imprecision, which means personalization cannot overcome weak or uncertain evidence . For tension-type headache, the guideline-supported treatments are condition-specific, underscoring that personalized care still depends on established diagnostic criteria and recommended therapies rather than generic goal-setting .

Mainstream view

Mainstream medicine supports individualized, evidence-based care plans that are adapted to the patient’s diagnosis, comorbidities, preferences, and treatment response, but only within the boundaries of validated clinical guidance. The phrase 'develop a personalized protocol to support your goals and needs' is too nonspecific to be judged strongly true or false as a medical claim; as written, it is a generic wellness statement with weak evidentiary content, and it becomes clinically meaningful only when tied to a specific condition and protocol.

Papers listed for this claim:[4][8][13][15][14][16][17][18]

In their own wordsView sourceArchived copy

“develop a personalized protocol to support your goals and needs”

Rule: K.S.A. 65-2871

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise we help create an internal environment that supports healing alongside your medical care as within their scope of practice.

we help create an internal environment that supports healing alongside your medical care

Supports

The influencer’s claim is very general, but there is substantial evidence that various adjunctive or supportive interventions can improve the “internal environment” for healing (e.g., quality of life, symptom control, psychological state) when used alongside standard medical care. Major guidelines in nutrition and supportive care recognize that adequate clinical nutrition and metabolic support are integral to recovery and healing in many conditions, and they are specifically framed as working alongside disease-directed therapies. Evidence-based hypertension and cardiovascular guidelines similarly emphasize lifestyle measures (diet, exercise, weight management, limited alcohol, stress reduction) as essential adjuncts that improve blood pressure control and cardiovascular outcomes in addition to drugs, which can be interpreted as optimizing the patient’s internal milieu for healing. A systematic review and meta-analysis of lifestyle modification programmes for coronary heart disease showed that comprehensive programmes alongside standard care reduced all-cause and cardiac mortality and cardiac readmissions, indicating that structured lifestyle changes can materially support recovery and long-term outcomes. In oncology and chronic disease, multiple randomized and observational studies of integrative or supportive care programs (including mind–body, exercise, nurse-led complementary therapies, and structured supportive care) show improvements in quality of life, fatigue, pain, psychological distress, or symptom burden when delivered in addition to routine medical treatment, which aligns with the idea of creating a more supportive internal environment rather than replacing conventional care. There is also guideline-level endorsement of structured pain management, blood transfusion when indicated, and other supportive measures as critical components of comprehensive care that facilitate recovery and healing.

Contradicts

The claim is vague and nonspecific about what is meant by “creating an internal environment” and what specific interventions are used, so it is not directly testable against high-quality evidence; most RCTs and guidelines evaluate defined interventions, not broad holistic slogans. Some randomized trials of integrative or complementary add-ons to standard oncology care have found little or no benefit on global quality of life or resilience, indicating that not all such programs meaningfully improve the patient’s internal or experiential environment. In addition, a randomized trial of open dialogue about complementary and alternative medicine in cancer care showed no improvement in quality of life or well-being versus standard care, suggesting that simply adding more discussion or loosely structured integrative elements does not necessarily enhance healing-related outcomes. Evidence-based methodology frameworks such as GRADE emphasize that imprecision, bias, and heterogeneity often limit certainty about benefits of many adjunctive or complementary interventions, highlighting that broad claims of “supporting healing” may overstate what current data can robustly demonstrate for any given proprietary program. High-quality guidelines for headaches, blood transfusion, and many other conditions focus primarily on specific pharmacologic and procedural treatments with clearly demonstrated benefit, and they typically do not endorse generic, unvalidated “internal environment” programs, especially when these are commercial or loosely defined.

Mainstream view

Mainstream medical and scientific opinion strongly supports the use of evidence-based supportive measures—such as optimized nutrition, guideline-directed lifestyle modification, psychological support, rehabilitation, palliative and supportive care services, and appropriate symptom control—alongside disease-directed medical treatments to improve outcomes, function, and quality of life. It is widely accepted that such measures help create more favorable physiological and psychological conditions for recovery, but they are expected to be specific, measurable, and consistent with guideline-based care rather than vague or implied to substitute for effective standard therapies. In oncology, cardiology, critical care, and chronic disease management, integrative or supportive programs are increasingly used within mainstream systems, but their components are ideally evaluated in controlled trials; some interventions show clear benefit while others show little or no added effect, so broad claims must be tempered by the actual evidence base for each component. Overall, the mainstream view is that fostering a supportive internal environment through validated lifestyle, nutritional, psychological, and rehabilitative interventions is appropriate and beneficial when done transparently and adjunctively, but generic or commercial claims that any particular unspecified

Papers listed for this claim:[4][8][13][15][16][14][17][18][59][60][61][62]

In their own wordsView sourceArchived copy

“we help create an internal environment that supports healing alongside your medical care”

Rule: K.S.A. 65-2871

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure We work to identify triggers such as gut dysfunction, infections, environmental toxins, and chronic stress.

We work to identify triggers such as gut dysfunction, infections, environmental toxins, and chronic stress

Supports

The influencer’s statement is very general, but parts of it are consistent with mainstream evidence that certain factors can act as “triggers” or modifiers for specific chronic diseases, particularly inflammatory and stress‑related conditions. Gut dysfunction: Multiple reviews describe gut microbiota dysbiosis and impaired barrier function (“leaky gut”) as contributors to chronic inflammatory and immune‑mediated diseases (e.g., inflammatory bowel disease, rheumatoid arthritis, multiple sclerosis, cardiometabolic disease), framing gut dysfunction as an upstream factor or trigger of chronic inflammation and disease flares. Stress: Reviews on inflammatory bowel disease report that psychological stress can precipitate or exacerbate IBD flares in both adults and children, describing stress as a promoting or relapsing factor and recommending stress management as part of care. Environmental toxins: Environmental exposures such as pollutants and xenobiotics are discussed as risk modifiers in chronic inflammatory and metabolic diseases, with evidence that heavy metals and other toxins can worsen conditions like COPD, chronic kidney disease, and possibly contribute to chronic inflammation and organ dysfunction. Infections: Chronic or past infections and infection‑driven dysbiosis are described as contributors to chronic low‑grade inflammation and some immune‑mediated diseases; typical causes of chronic inflammation include certain infections, and infection‑related disturbances of the microbiota are considered possible upstream drivers in some chronic conditions. Overall, there is reasonable support that gut dysfunction, certain infections, some environmental toxins, and chronic stress can act as triggers or exacerbating factors for specific chronic diseases, especially inflammatory and immune‑mediated conditions, when considered in the appropriate clinical context.

Contradicts

The claim as phrased is very broad and nonspecific (“identify triggers such as gut dysfunction, infections, environmental toxins, and chronic stress”) and could be interpreted as implying that these factors are dominant or universal triggers for most or all health problems, which is not supported by high‑quality evidence. Many chronic diseases have multifactorial etiologies (genetic, age‑related, metabolic, lifestyle, and environmental), and reviews emphasize that gut dysbiosis, infections, toxins, and stress are typically modifiers or contributors rather than sole or universal causes. Evidence that “gut dysfunction” in a vague, functional‑medicine sense is a primary trigger for a wide range of unrelated conditions remains limited; much of the research is associative (cross‑sectional, observational) and does not prove causation or justify broad clinical claims. Similarly, while chronic stress can exacerbate conditions like IBD, it is not established as a direct causal trigger for most chronic diseases in the strong sense often implied by influencers; guidelines for common chronic diseases (e.g., hypertension management, nutrition guidelines) focus primarily on blood pressure, diet, weight, smoking, and pharmacotherapy, and only secondarily on psychosocial factors. The evidence for “environmental toxins” as a general trigger is heterogeneous: specific toxins (e.g., heavy metals, air pollutants) have documented organ‑specific risks, but evidence does not support routine broad “toxin hunting” or generalized detox approaches as standard of care in most patients. Overall, the major gap is that high‑quality trials or guidelines rarely endorse broad, non‑specific clinical programs centered on systematically “identifying” these triggers in all patients with chronic symptoms; instead, they recommend targeted evaluation based on established risk factors for each disease.

Mainstream view

Mainstream medicine recognizes that gut microbiota disturbances, some infections, selected environmental exposures, and psychological stress can contribute to the development or exacerbation of certain chronic and inflammatory diseases, but it treats these factors as part of a multifactorial picture rather than universal root causes. For well‑defined diseases such as inflammatory bowel disease, rheumatic diseases, and some cardiometabolic conditions, guidelines acknowledge roles for environmental factors, infections, and stress, but evidence‑based management still centers on disease‑specific pharmacologic therapy, lifestyle measures (diet, exercise, smoking cessation), and psychosocial support, not on broad, non‑standard “trigger identification” protocols. Assessment of toxins or infections is typically targeted

Papers listed for this claim:[4][8][13][15][16][14][17][18][63][64][65][66]

In their own wordsView sourceArchived copy

“We work to identify triggers such as gut dysfunction, infections, environmental toxins, and chronic stress”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on IBS, SIBO and gut disorders

Corey M. Priest is not approved to offer supporting detox pathways, and restoring immune regulation within a Chiropractor scope of practice under Kansas State Board of Healing Arts (Chiropractic).

supporting detox pathways, and restoring immune regulation

Supports

High-quality evidence shows that certain targeted lifestyle and nutritional interventions can modulate detoxification pathways and aspects of immune regulation, but this support is specific and limited rather than broad. A 2024 phase II randomized, blinded, placebo-controlled trial of a plant-based dietary supplement found significant changes in biomarkers of metabolic detoxification (reduced red blood cell toxic metals, urine porphyrins, urine mutagenicity) and improved quality-of-life scores over 28 days, supporting the idea that nutritional interventions can support hepatic metabolic detoxification in otherwise healthy people with symptoms of elevated toxin burden. A 2015 clinical review reports that various foods and food-derived components can influence phase I cytochrome P450 enzymes, phase II conjugation enzymes, Nrf2 signaling, and metallothionein, indicating that diet can modulate metabolic detox pathways in humans, although effects are pathway- and compound-specific. Systematic and randomized studies on diet and immune biomarkers show that dietary patterns can affect inflammatory and immune response markers, suggesting some capacity to influence immune function via nutrition, though not “restore” regulation in a simple, universal sense. Randomized controlled trials of yoga-based and psychological or lifestyle interventions demonstrate changes in immune-related markers and reductions in proinflammatory cytokines, supporting that stress reduction, physical activity, and mind–body practices can help modulate immune responses and improve immune regulation in specific clinical contexts such as rheumatoid arthritis. Narrative and systematic reviews on micronutrients such as zinc, selenium, and vitamin C confirm established roles in immune cell function, antioxidant defense, and inflammatory regulation, and show clinical benefit particularly in deficient individuals, which supports the concept that appropriate nutrient status can help maintain normal immune regulation.

Contradicts

The available high-quality evidence does not support a broad, generic claim that interventions can globally “support detox pathways and restore immune regulation” in the way such phrases are often used in influencer content. Most detox-related evidence focuses on specific metabolic pathways (hepatic phase I/II enzymes, oxidative stress markers, specific toxins) and shows modest, biomarker-level changes over short periods, rather than comprehensive removal of unspecified “toxins” or clinical disease reversal. The plant-based detox supplement trial involved only 40 participants, short follow-up, and biomarker rather than hard clinical outcomes, so it provides preliminary, not definitive, evidence; it does not show restoration of immune regulation. Reviews of dietary supplements for immune health emphasize that benefits are context-dependent, often limited to correcting deficiencies, and that excessive supplementation can be ineffective or harmful, contradicting simple claims that more supplementation universally improves or “restores” immune regulation. Trials of lifestyle and mind–body interventions show changes in specific immune markers or inflammatory cytokines, but these effects are variable, modest, and population-specific; they do not justify strong, generalized claims of immune “reset” or complete restoration of immune regulation in healthy populations. Evidence from detox and immune-modulating interventions is still evolving, frequently limited by small sample sizes, short durations, and surrogate outcomes, so there is weak support for broad therapeutic promises commonly made in influencer narratives. The listed clinical trials (miconazole resistance in infants, chemotherapy pharmacokinetics in pancreatic cancer, autophagy/anti-aging effects of metformin, swaddle bathing safety, GI remote examination, vocal cord palsy risk factors, text neck syndrome stretches, hepatic impairment pharmacology) are unrelated to generalized detox or immune restoration and therefore do not substantiate the influencer’s claim.

Mainstream view

Mainstream medical and scientific views recognize that detoxification and immune regulation are normal physiological processes primarily maintained by organs such as the liver, kidneys, gut, and immune system, and that in healthy individuals these systems are usually adequate without the need for special “detox” products. Evidence-based practice supports specific interventions when there is a defined problem: for example, treating liver disease, managing toxin exposures with established therapies, correcting nutritional deficiencies that impair immune function, and using immunomodulatory drugs in autoimmune or inflammatory conditions. Dietary patterns, regular physical activity, stress reduction, adequate sleep, and avoidance of harmful exposures are accepted as contributing to optimal function of detoxification enzymes and balanced immune responses, but mainstream guidelines typically frame these as components of general health rather than as targeted “detox” or “immune reset” therapies. High-quality trials and reviews on detoxifying supplements and immune-support products are still limited, and professional bodies emphasize cautious interpretation of preliminary biomarker changes

Papers listed for this claim:[67][68][69][70]

In their own wordsView sourceArchived copy

“supporting detox pathways, and restoring immune regulation”

Rule: K.S.A. 65-2871

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure focus on restoring gut integrity, balancing the microbiome, and improving digestion and absorption.

focus on restoring gut integrity, balancing the microbiome, and improving digestion and absorption

Supports

Clinical nutrition guidelines for inflammatory bowel disease emphasize optimizing digestion and nutrient absorption via appropriate diet, enteral nutrition, and supplementation, reflecting the importance of gut function and barrier integrity to overall health and disease outcomes. ASPEN–FELANPE clinical nutrition guidelines similarly prioritize maintaining gastrointestinal function and maximizing enteral nutrition when feasible, aiming to support mucosal integrity and nutrient absorption as central goals of nutrition care. Guidelines on appropriate use of parenteral nutrition stress that it is reserved for situations where gut function (digestion/absorption) is inadequate or unsafe, underscoring that normal management aims to use and preserve the gut whenever possible. Recent systematic reviews and meta-analyses show that probiotics, prebiotics, and synbiotics can improve markers of intestinal permeability (“leaky gut”) such as serum zonulin and lipopolysaccharide in various populations, indicating that microbiome-targeted interventions can positively influence gut barrier integrity, although evidence certainty is often low to moderate and heterogeneous. Narrative and systematic reviews on intestinal barrier impairment report that diet, specific nutrients (e.g., fiber, glutamine, zinc, vitamin D, polyphenols), and the microbiome can modulate gut permeability and barrier function, supporting the biological plausibility that improving gut integrity and microbiome composition can benefit health. Clinical trials of prebiotic-enriched foods (e.g., galacto-oligosaccharides-containing milk) demonstrate measurable changes in gut microbiota (such as increased bifidobacteria) and metabolites associated with immune and metabolic health, consistent with the idea that targeted nutrition can modulate the microbiome with potential health benefits. Reviews on biotics (prebiotics, probiotics, synbiotics, postbiotics) conclude that these agents can enhance intestinal epithelial integrity and modulate gut microbiota across conditions like inflammatory bowel disease, irritable bowel syndrome, obesity, and antibiotic-associated diarrhea, further supporting the concept that microbiome modulation and barrier support are clinically relevant targets.

Contradicts

The influencer’s claim is broad and implies that restoring gut integrity, balancing the microbiome, and improving digestion and absorption should be a primary or universal focus for health, but the listed guidelines (hypertension, tension-type headache, blood transfusion, pericarditis) do not prioritize gut integrity or the microbiome as core management strategies in these conditions. This indicates that while gut health is important, it is not the central therapeutic focus across unrelated diseases. Evidence for microbiome-targeted strategies and gut barrier restoration is still evolving: systematic reviews and meta-analyses of probiotics, prebiotics, and synbiotics frequently report high heterogeneity, variable effect sizes, and low to moderate certainty of evidence, meaning that benefits on clinical endpoints (e.g., symptom resolution, hard outcomes) are not consistently established across populations. Many existing studies focus on surrogate markers such as zonulin, lipopolysaccharide, or microbiota composition rather than robust patient-centered outcomes (mortality, major morbidity, quality of life), so claims that focusing on gut integrity and microbiome balance will reliably improve overall health or specific diseases are not strongly supported at the guideline level. Current consensus documents on malabsorption and clinical nutrition emphasize individualized assessment of specific diseases and nutritional status rather than a generic protocol of “restoring gut integrity” for everyone, suggesting that a one-size-fits-all recommendation to focus on gut integrity and microbiome balance over established disease-specific therapies is not evidence-based.

Mainstream view

Mainstream clinical practice acknowledges that the gut barrier, microbiome, and effective digestion and absorption are important for health, particularly in gastrointestinal diseases and in patients at nutritional risk, and major nutrition guidelines integrate strategies to preserve or restore gut function when clinically indicated. There is growing, biologically plausible evidence that diet and microbiome-targeted interventions can modulate intestinal permeability and microbiota composition, with potential downstream effects on inflammation and systemic health, but current evidence is mixed, often based on surrogate markers, and not yet sufficient to support broad claims that gut integrity and microbiome balance should be the primary focus of disease management for most conditions. Mainstream medicine therefore supports attention to gut health and appropriate use of microbiome-modulating and nutrition strategies within evidence-based, condition

Papers listed for this claim:[4][8][13][15][14][16][17][18][71][72][73][74]

In their own wordsView sourceArchived copy

“focus on restoring gut integrity, balancing the microbiome, and improving digestion and absorption”

Rule: K.S.A. 65-2871

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to advertise A functional approach focuses on addressing underlying infections, supporting immune resilience, and restoring balance to help the body recover more effectively as within their scope of practice.

A functional approach focuses on addressing underlying infections, supporting immune resilience, and restoring balance to help the body recover more effectively

Supports

Major clinical guidelines across different conditions endorse identifying and appropriately treating infections as a core part of care, and they emphasize supporting overall physiological and immune function, but they do not frame this as a distinct “functional approach.” For example, nutrition guidelines for hospitalized and critically ill patients stress maintaining adequate macro- and micronutrient intake to support immune function and recovery, which conceptually aligns with “supporting immune resilience” and “restoring balance” through evidence‑based nutrition rather than alternative protocols. Clinical nutrition guidance in chronic inflammatory conditions (e.g., inflammatory bowel disease) similarly promotes tailored nutrition support to correct malnutrition, reduce inflammation, and improve outcomes, which indirectly supports immune competence and systemic homeostasis. Transfusion therapy guidelines aim to correct specific deficits (e.g., anemia, coagulopathy) to restore physiological balance and support recovery, again focusing on targeted, evidence‑based interventions rather than broad “functional” frameworks. High‑quality conceptual and mechanistic work on immune resilience shows that maintaining or rapidly restoring immune competence while controlling inflammation is associated with better infection outcomes, longevity, and recovery, supporting the general idea that “immune resilience” and balanced immune responses are important determinants of how effectively the body recovers after stress or infection. Outside the list, sepsis and COVID‑19 research on immunologic or immune resilience similarly supports the importance of preserving immune function and resolving inflammation for better recovery trajectories. Overall, mainstream evidence supports the principles that treating infections appropriately, maintaining adequate nutrition, correcting physiological derangements, and supporting balanced immune responses improve recovery, which partially overlaps with the influencer’s broad framing but is operationalized in standard evidence‑based care rather than in a distinct “functional” paradigm.

Contradicts

The influencer’s claim implies that a “functional approach” centered on underlying infections, immune resilience, and restoring balance is a superior or distinct method for improving recovery across conditions. Major guidelines in hypertension, clinical nutrition, headache, transfusion medicine, and other areas do not endorse functional medicine or broad infection‑centered protocols as first‑line or preferred strategies. Instead, they emphasize disease‑specific risk stratification, pharmacologic therapy, conventional antimicrobial management when infection is present, and targeted supportive care. There is limited or no high‑quality evidence (large RCTs, meta‑analyses, major guidelines) showing that generic “functional” protocols—such as extensive infection workups in the absence of clear indications, long or unconventional antimicrobial regimens, or comprehensive “immune resilience” supplement programs—systematically improve recovery beyond standard guideline‑based care. Existing work on immune resilience is largely observational, mechanistic, or early‑stage; it supports immune resilience as an important concept but does not validate specific commercial or influencer‑promoted functional medicine treatment packages as clinically superior approaches. Therefore, while components of the claim are individually consistent with mainstream biology (infections matter, immune balance matters), the suggestion that a functional approach defined in this way is broadly more effective for recovery is not currently backed by strong clinical trial or guideline‑level evidence.

Mainstream view

Mainstream medical practice holds that effective recovery from illness depends on accurate diagnosis, evidence‑based treatment of identified diseases (including infections), and targeted supportive care (e.g., nutrition support, transfusion when indicated, symptom management), guided by high‑quality clinical trials and formal guidelines. Underlying infections are investigated and treated when there are clinical indications or risk factors, using established diagnostic methods and antimicrobial regimens. Immune function and systemic balance are supported through proven measures such as appropriate nutrition, vaccination, control of comorbidities, avoidance of immunosuppressive harms, and, in specific contexts, immunomodulatory therapies validated in trials. The concept of immune resilience—preserving or restoring immune competence while controlling inflammation—is increasingly recognized as important for prognosis and recovery, but it is integrated into conventional research and care rather than through unvalidated functional medicine programs. Overall, mainstream medicine partially shares the stated goals (address infections when present, support immune health, maintain physiological balance) but relies on standardized, evidence‑based interventions and does not endorse broad, poorly defined “functional” approaches as superior or general recovery strategies.

Papers listed for this claim:[4][8][13][15][14][16][17][75][76][77][78][79]

In their own wordsView sourceArchived copy

“A functional approach focuses on addressing underlying infections, supporting immune resilience, and restoring balance to help the body recover more effectively”

Rule: K.S.A. 65-2871

Corey M. Priest is not approved to offer Treatment centers on identifying exposure, supporting detoxification, and calming the body’s inflammatory response to promote healing within a Chiropractor scope of practice under Kansas State Board of Healing Arts (Chiropractic).

Treatment centers on identifying exposure, supporting detoxification, and calming the body’s inflammatory response to promote healing

Supports

Across many conditions, mainstream treatment frameworks include elements that resemble parts of this claim: identifying and removing a harmful exposure (e.g., stopping offending drugs, allergens, toxins, or injurious behaviors), modulating inflammation when it is a key driver of disease, and supporting organ function while healing occurs. For example, guideline-based management of hypertension emphasizes identifying and modifying exposures such as excess sodium, alcohol, and other lifestyle factors, and then using pharmacologic therapy (e.g., ACE inhibitors, ARBs) that also have anti-inflammatory and vascular-protective effects, while monitoring and supporting cardiovascular and renal function. Similarly, nutrition guidelines in inflammatory bowel disease recommend avoiding dietary triggers, correcting deficits, and using nutrition (enteral/parenteral) to support gut barrier and systemic health in parallel with disease-modifying and anti‑inflammatory therapies. In medication‑overuse headache, evidence‑based guidelines recommend identifying the offending medication exposure and withdrawing it (“detoxification”) while providing supportive and preventive therapy to calm the sensitized nervous system and reduce the chronic inflammatory‑like pain state. In critical care and perioperative medicine, blood transfusion and parenteral nutrition are framed as supportive therapies that maintain oxygen delivery and nutrition while underlying disease processes and inflammatory responses are treated with specific interventions. High‑quality methodology papers (GRADE, meta‑analysis methods) and major guidelines together show that modern evidence‑based care often integrates exposure identification, targeted anti‑inflammatory or disease‑modifying agents, and organ support, but always in a disease‑specific, not generic “detox” paradigm.

Contradicts

The claim, as phrased, implies that for illness in general, treatment “centers on identifying exposure, supporting detoxification, and calming the inflammatory response” as if this triad is the primary, universal core of therapy. Major evidence‑based guidelines for conditions like hypertension and tension‑type headache instead emphasize disease‑specific mechanisms (e.g., neurovascular regulation, central pain processing) and targeted pharmacologic and nonpharmacologic treatments, not generic detoxification protocols. The ASPEN‑FELANPE guidelines and related parenteral nutrition guidance explicitly caution that nutrition and organ support are adjuncts used when indicated, not universal detoxification strategies, and they must be applied in a highly individualized, risk‑benefit framework. Evidence reviews of “detox diets” show very limited and low‑quality data for broad claims of enhancing detoxification or promoting healing, and no robust randomized trials demonstrating that generic detox programs improve health outcomes across conditions, which directly contradicts the idea that supporting detoxification is a central evidence‑based pillar of treatment for most illnesses. Methodological standards such as the GRADE guidelines emphasize that high‑quality recommendations must be disease‑ and intervention‑specific, and they do not endorse broad, system‑wide claims like this when the evidence base is heterogeneous or weak. Overall, existing high‑quality guidelines for common disorders rarely define treatment around a generic detox‑plus‑anti‑inflammatory triad, but around specific pathophysiology, risk modification, and proven therapies, which makes the influencer’s framing overly simplistic and not well supported by current evidence.

Mainstream view

Mainstream evidence‑based medicine recognizes three ideas embedded in the claim, but in a much more constrained way: identifying and eliminating a proven harmful exposure (e.g., toxic agents, offending drugs, high‑risk behaviors) is important when such an exposure is clearly established; modulating inflammation is central in diseases where inflammation is a primary driver (e.g., autoimmune disease, some cardiovascular and gastrointestinal conditions), using specific anti‑inflammatory or immunomodulatory therapies; and supporting organ function (nutrition, hemodynamics, oxygen delivery, symptom control) is a critical adjunct while definitive treatment is delivered. However, mainstream guidelines do not treat “supporting detoxification” as a generalized therapeutic centerpiece across conditions, and they do not present a universal model in which identifying some unspecified exposure, boosting detoxification, and “calming inflammation” is sufficient to promote healing. Instead, they emphasize precise diagnosis, disease‑specific causal mechanisms, targeted pharmacologic and procedural treatments, structured lifestyle

Papers listed for this claim:[4][13][8][15][14][16][80][17][81][82][83][84]

In their own wordsView sourceArchived copy

“Treatment centers on identifying exposure, supporting detoxification, and calming the body’s inflammatory response to promote healing”

Rule: K.S.A. 65-2871

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure We evaluate imbalances and create strategies to restore harmony across your endocrine system.

We evaluate imbalances and create strategies to restore harmony across your endocrine system

Supports

High-quality evidence supports guideline-based, disease-specific management of endocrine and related systemic disorders, where clinicians identify clinically relevant abnormalities (e.g., hypothyroidism, diabetes, adrenal insufficiency) and use evidence-based therapies to correct them, which can be described conceptually as restoring normal physiologic function or hormonal homeostasis. Major practice guidelines in other domains, such as hypertension management, emphasize systematic evaluation of measurable abnormalities (blood pressure, comorbidities, target organ damage) and use of standardized therapeutic strategies to bring values back toward guideline-defined target ranges, which is analogous in structure to evidence-based endocrine care, though not specifically endocrine-focused. The ASPEN-FELANPE and ESPEN guidelines show that for nutritional and metabolic disturbances, expert groups develop protocols to correct imbalances (e.g., malnutrition, micronutrient deficiencies, metabolic complications) in a structured, guideline-driven way, reinforcing that "imbalance" correction is appropriate when defined by validated clinical criteria and lab measures.

Contradicts

There is no high-quality evidence that generic, holistic, or influencer-led programs can reliably "evaluate imbalances" across the entire endocrine system or "restore harmony" without anchoring these claims in specific diagnoses, validated biomarkers, and guideline-supported interventions. The cited guidelines for hypertension, clinical nutrition, parenteral nutrition, headache, blood transfusion, and pericarditis emphasize rigorously defined conditions, validated diagnostic thresholds, and treatments with quantified benefits and risks, rather than vague notions of systemic imbalance or harmony. These documents illustrate that mainstream evidence-based medicine does not endorse broad endocrine "rebalancing" frameworks lacking specific pathophysiology, outcome measures, and randomized trial support. The claim suggests a comprehensive capacity to normalize the entire endocrine system, but there are no major guidelines, RCTs, or meta-analyses supporting such generalized interventions; evidence is limited to condition-specific endocrine treatments (e.g., thyroid hormone replacement, insulin therapy), not global harmony strategies. Use of imprecise constructs like "imbalances" and "harmony" is inconsistent with GRADE principles, which stress clearly defined outcomes, effect sizes, and precision in estimating benefits and harms.

Mainstream view

The mainstream medical position is that endocrine disorders should be diagnosed through standardized clinical criteria, targeted history and examination, and validated laboratory or imaging tests, followed by guideline-driven, disease-specific management aimed at correcting defined abnormalities (e.g., hormone levels, glycemic control, blood pressure) and improving patient-centered outcomes. Influencer language about restoring harmony across the endocrine system does not align with evidence-based frameworks unless it is grounded in specific, measurable endocrine conditions and treatments with demonstrated efficacy. Major guidelines across specialties (hypertension, clinical nutrition, neurology, transfusion, cardiology) exemplify the expectation that interventions address clearly characterized disorders using therapies backed by robust trials and systematic reviews, rather than generalized concepts of imbalance. Mainstream clinicians therefore view global endocrine "rebalancing" claims as unsubstantiated unless tied to recognized endocrine diagnoses and established therapeutic protocols.

Papers listed for this claim:[4][8][13][15][16][14][17][18]

In their own wordsView sourceArchived copy

“We evaluate imbalances and create strategies to restore harmony across your endocrine system”

Rule: K.S.A. 65-2871

Corey M. Priest is not licensed or approved by Kansas State Board of Healing Arts (Chiropractic) to diagnose, treat, or cure Care focuses on restoring mitochondrial health, balancing hormones, and reducing underlying inflammation.

Care focuses on restoring mitochondrial health, balancing hormones, and reducing underlying inflammation

Supports

High-quality evidence does support disease-specific use of nutrition and anti-inflammatory treatment in some conditions, such as inflammatory bowel disease nutrition management and colchicine for pericarditis. General evidence-based care also emphasizes using interventions with proven clinical benefit rather than broad mechanistic claims, and guideline-based management exists for hypertension and nutrition support in serious illness.

Contradicts

The claim is framed as a broad promise that care focuses on restoring mitochondrial health, balancing hormones, and reducing underlying inflammation, but the cited guidelines do not support those as universal primary treatment targets across medical care. Mitochondrial health and hormone balancing are not established as routine overarching clinical endpoints in the listed guideline papers, and the evidence base for these concepts as generalized treatment goals is weak or condition-specific rather than broadly validated.

Mainstream view

Mainstream medicine does not view restoring mitochondrial health, balancing hormones, and reducing underlying inflammation as a single evidence-based framework for care across conditions. Instead, clinicians treat the specific diagnosed disease with therapies supported by guidelines and trials, and only use anti-inflammatory, hormonal, or metabolic interventions when there is direct evidence they help that particular condition.

Papers listed for this claim:[4][8][13][15][14][16][17][18]

In their own wordsView sourceArchived copy

“Care focuses on restoring mitochondrial health, balancing hormones, and reducing underlying inflammation”

Rule: K.S.A. 65-2871

See every doc bro who says they can treat or advise on Hormone imbalance and replacement